Status:
COMPLETED
Addressing Insufficient PAP Use in Older Veterans
Lead Sponsor:
VA Office of Research and Development
Conditions:
Sleep Apnea
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a common problem among middle-aged and older Veterans that is associated with poor nighttime sleep, more daytime sleepiness, poor functioning and worse quality of life...
Detailed Description
Background: The most frequently diagnosed sleep disorder among middle-aged and older Veterans is obstructive sleep apnea (OSA), which is associated with serious adverse effects on health, quality of l...
Eligibility Criteria
Inclusion
- Diagnosis of moderate to severe obstructive sleep apnea (apnea hypopnea index \[AHI\] \> or = 15)
- Previously prescribed positive airway pressure (PAP) therapy
- Insufficient PAP use (defined as no PAP use over the past 30 days)
Exclusion
- Severe psychopathology (e.g., active psychosis) that precludes participation in the study
- Severe unstable medical illness that precludes participation in the study
- Significant cognitive impairment
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04868682
Start Date
January 10 2022
End Date
September 30 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Greater Los Angeles Healthcare System, Sepulveda, CA
Sepulveda, California, United States, 91343